This content has not yet been reviewed and may contain errors.

dialysis complications

in review 4 min read Updated 2026-08-24
Contents
HD complications centre on access (infection, dysfunction, hypotension) and PD complications on peritonitis and catheter issues. Catheter removal decisions in HD require extra caution — the catheter may be the patient’s last viable access.
emergencies
  • Bleeding AVF/AVG — vascular emergency → direct pressure, call vascular surgery
  • Air embolism — rare (damaged PermCath); terminate HD immediately → left lateral decubitus, Trendelenburg
  • Severe intradialytic hypotension unresponsive to fluid — consider sepsis, cardiac tamponade, anaphylaxis

intradialytic hypotension

Excessive ultrafiltration relative to intravascular refilling rate. Most common acute HD complication.

Assessment: volume status and target weight accuracy, sepsis, cardiac dysfunction (new or worsening).

Management — stepwise:

StrategyIntervention
Reduce fluid removalLower UF rate; NS 250 mL boluses PRN
Increase refilling25% albumin 100 mL; increase dialysate Na
Increase PVRHold antihypertensives pre-HD; midodrine 5–10 mg pre-HD; cool dialysate (35.5 C)

If recurrent → reassess dry weight (may be set too low), consider longer/more frequent sessions, or isolated UF + HD split runs.


catheter dysfunction

Causes: fibrin sheath (most common), venous stenosis, volume depletion, catheter malposition.

tPA options

ProtocolDoseMethod
BlockCathflo 1 mg per portInstil post-dialysis, dwell in catheter
DwellCathflo 1 mg IVDwell for duration of dialysis
AdvanceCathflo 1 mg IVAdvance into catheter for dialysis
SystemicCathflo 4 mg in 50 mL NSSystemic infusion once on machine

Contraindications: recent stroke, major surgery, active bleeding.

Persistent dysfunction despite tPA → interventional radiology catheter study or catheter exchange over wire.


HD catheter infections

catheter removal calculus

Removing an HD catheter is not a simple decision. For some patients, the catheter is their last viable access — removal = no dialysis. Always weigh infection severity against access options.

Obtain CBC, wound swab, and line cultures for all suspected infections.

exit site infection

Erythema/warmth/tenderness <2 cm from exit site, with or without fever/bacteraemia.

  • MRSA-negative: cefazolin 1–2 g IV post-HD
  • MRSA-positive/unknown/cefazolin allergy: vancomycin 20–25 mg/kg IV load post-HD, then per-HD dosing guided by levels
  • Catheter removal: generally not required

tunnel infection

Erythema/warmth/tenderness >2 cm from exit site, tracking along subcutaneous tunnel.

  • Gram-positive: cefazolin 2 g IV or vancomycin 20–25 mg/kg post-HD
  • Gram-negative: ceftazidime 2 g IV daily or piperacillin-tazobactam 4.5 g IV q6h
  • Catheter removal: generally required

Positive blood culture with or without local signs.

  • Coverage as per tunnel infection (dual gram-positive + gram-negative)
  • Catheter removal: generally required

AVF/AVG complications

  • Dysfunction — absent thrill/bruit and/or inadequate dialysis → fistulogram (IR)
  • Infection — treat as per catheter infections + ultrasound to rule out abscess; may need IR or surgical intervention
  • Bleeding — direct pressure; if uncontrolled → vascular emergency
  • Steal syndrome — hand ischaemia distal to fistula → vascular surgery referral

PD complications

PD peritonitis

Diagnose with 2 of 3:

  1. Abdominal pain and/or cloudy effluent
  2. PD fluid WBC >100 x 10^6/L with >50% PMN
  3. Positive PD fluid culture

Workup: CBC, exit site swab, PD fluid cell count + culture (in blood culture bottles), blood cultures.

Empiric treatment: cefazolin 1 g IP daily + ceftazidime 1 g IP daily x 2 weeks (extend to 3 weeks if Pseudomonas).

PCN allergy or MRSA: vancomycin 2 g IP every 5 days x 3 doses.

PD peritonitis pearls

Cloudy bag + abdominal pain in a PD patient = peritonitis until proven otherwise. Send PD fluid before starting antibiotics but do not delay treatment. Intraperitoneal dosing is preferred over IV.

exit site and tunnel infections

  • Exit site — purulent discharge with or without erythema → cephalexin 500 mg PO TID x 2 weeks (3 weeks if Pseudomonas)
  • Tunnel — clinical inflammation + ultrasound fluid along tunnel → cephalexin 500 mg PO; may need catheter removal

catheter dysfunction

Number one cause: constipation. Confirm catheter position on AXR, then uptitrate laxatives (sometimes requires full bowel prep).

PD hyperglycaemia

Dianeal dextrose solutions deliver a significant glucose load → adjust insulin. Extraneal (icodextrin) has minimal glucose effect — preferred for diabetics and long dwells.


traps

  • Repeating lytes immediately post-HD → they will be transiently abnormal; only recheck if concerned about dialysis adequacy or persistent hyperkalaemia
  • Ordering PICC/CVL in a CKD or dialysis patient → destroys future access sites
  • Correcting mild hypokalaemia in a dialysis patient → risk of rebound hyperkalaemia; only treat if K <2 mmol/L or symptomatic
  • Removing HD catheter reflexively for infection without checking if alternative access exists
  • Forgetting constipation as the cause of PD catheter dysfunction — it is the most common cause

Key references